Toughened polylactic acid polymers and copolymers

US2016355677A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016355677-A1
Application numberUS-201615242993-A
CountryUS
Kind codeA1
Filing dateAug 22, 2016
Priority dateFeb 7, 2006
Publication dateDec 8, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Toughened compositions of PLA and PLA copolymers are disclosed, which also have low tensile modulus values and greater elongation to break. These toughened compositions are prepared by blending PLA and PLA copolymers with poly-4-hydroxybutyrate, and copolymers thereof. Blending of poly-4-hydroxybutyrate with PLA and its copolymers has been found to impart advantageous properties to the resulting blend. These compositions, and objects formed from these compositions, have improved toughness and lower stiffness than polylactic acid polymers or copolymers alone.

First claim

Opening claim text (preview).

We claim: 1 . A medical device comprising a toughened polymer composition comprising poly-4-hydroxybutyrate homopolymer or copolymer thereof wherein the composition further comprises at least one polylactic acid homopolymer or copolymer, and the amount of poly-4-hydroxybutyrate homopolymer or copolymer added is sufficient to increase the elongation to break of the composition to greater than the elongation to break of the polylactic acid homopolymer or copolymer. 2 . The medical device of claim 1 wherein the composition has been oriented. 3 . The medical device of claim 1 wherein the elongation to break of the composition is greater than 3%. 4 . The medical device of claim 3 wherein the elongation to break of the composition is between 3% and 281%. 5 . The medical device of claim 1 wherein the Young's modulus of the composition is less than the Young's modulus of the polylactic acid homopolymer or copolymer. 6 . The medical device of claim 5 wherein the Young's modulus of the composition is less than 700 kgf/mm 2 . 7 . The medical device of claim 1 wherein the ratio of the polylactic acid homopolymer or copolymer to the poly-4-hydroxybutyrate homopolymer is between 9:1 and 1:9 by weight. 8 . The medical device of claim 1 wherein the polylactic acid homopolymer is poly-L-lactic acid. 9 . The medical device of claim 1 wherein the device is a suture, suture fastener, meniscus repair device, rivet, tack, staple, screw, bone plate, bone plating system, biocompatible coating, rotator cuff repair device, surgical mesh, medical textile, repair patch, sling, cardiovascular patch, tissue engineering scaffold, vascular graft, vascular closure device, catheter balloon, anti-adhesion device, drug delivery device, embolization particle, orthopedic pin, adhesion barrier, stent (including coronary stents, peripheral stents, carotid stents, biliary stents, gastroenterology stents, urology stents, and neurology stents), embolization coil, guided tissue repair/regeneration device, articular cartilage repair device, nerve guide, tendon repair device, intracardiac septal defect repair device (including, but not limited to, atrial septal defect repair devices and PFO closure devices and left atrial appendage (LAA) closure devices), pericardial patch, bulking and filling agent, vein valves, bone marrow scaffold, meniscus regeneration device, ligament graft, tendon graft, ocular cell implant, spinal fusion cage, imaging device, skin substitute, dural substitute, bone graft substitute, bone dowel, would dressing, or a hemostat. 10 . A process for preparing the medical device of claim 1 , comprising blending poly-4-hydroxybutyrate homopolymer or copolymer thereof with at least one polylactic acid homopolymer or copolymer, wherein the poly-4-hydroxybutyrate homopolymer or copolymer thereof and at least one polylactic acid homopolymer are mixed in the molten state at a temperature between 110° C. and 230° C., and extruded. 11 . The process of claim 8 further comprising extruding the toughened composition, wherein the composition is dried to a water content of less than 0.01% (w/w) prior to extrusion, and wherein the composition is extruded at a temperature between 140° C. and 250° C. 12 . The process of claim 9 wherein the extrudate is oriented by drawing it with stretch ratios of 1X to 11X.

Assignees

Inventors

Classifications

  • C08L67/04Primary

    Polyesters derived from hydroxycarboxylic acids, e.g. lactones (C08L67/06 takes precedence) · CPC title

  • Mixtures of macromolecular compounds · CPC title

  • derived from hydroxycarboxylic acids · CPC title

  • Stabilisers against oxidation, heat, light or ozone · CPC title

  • Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016355677A1 cover?
Toughened compositions of PLA and PLA copolymers are disclosed, which also have low tensile modulus values and greater elongation to break. These toughened compositions are prepared by blending PLA and PLA copolymers with poly-4-hydroxybutyrate, and copolymers thereof. Blending of poly-4-hydroxybutyrate with PLA and its copolymers has been found to impart advantageous properties to the resultin…
Who is the assignee on this patent?
Tepha Inc
What technology area does this patent fall under?
Primary CPC classification C08L67/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).